Centenial Surgical Suture Ltd
            ₹ 108
            
              
                
                0.33%
              
            
          
          
            
              30 Oct
              
                - close price
              
            
          
        About
          Incorporated in 1995, Centenial Surgical Suture Ltd is engaged in manufacturing of surgical sutures & other medical devices.
Key Points
            - Market Cap ₹ 39.4 Cr.
- Current Price ₹ 108
- High / Low ₹ 189 / 82.2
- Stock P/E
- Book Value ₹ 84.3
- Dividend Yield 0.00 %
- ROCE 3.94 %
- ROE -4.64 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -0.77% over past five years.
- Company has a low return on equity of 0.60% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
      Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.96 | 51.71 | 51.39 | 52.84 | 52.73 | 56.05 | 55.61 | 36.93 | 44.43 | 52.66 | 51.19 | 53.49 | 52.72 | |
| 46.39 | 46.47 | 46.71 | 47.95 | 48.26 | 50.64 | 49.68 | 31.82 | 39.94 | 48.26 | 46.04 | 47.07 | 46.95 | |
| Operating Profit | 4.57 | 5.24 | 4.68 | 4.89 | 4.47 | 5.41 | 5.93 | 5.11 | 4.49 | 4.40 | 5.15 | 6.42 | 5.77 | 
| OPM % | 8.97% | 10.13% | 9.11% | 9.25% | 8.48% | 9.65% | 10.66% | 13.84% | 10.11% | 8.36% | 10.06% | 12.00% | 10.94% | 
| 0.04 | 0.10 | 0.02 | 0.01 | 0.05 | 0.02 | 0.09 | 0.09 | 0.04 | 0.13 | 0.13 | 0.12 | 0.12 | |
| Interest | 1.31 | 1.61 | 1.65 | 1.77 | 1.51 | 1.89 | 2.31 | 2.12 | 1.93 | 1.77 | 2.62 | 3.90 | 3.54 | 
| Depreciation | 0.59 | 0.83 | 0.68 | 0.59 | 0.60 | 0.69 | 1.55 | 1.55 | 1.53 | 1.30 | 1.39 | 4.25 | 4.41 | 
| Profit before tax | 2.71 | 2.90 | 2.37 | 2.54 | 2.41 | 2.85 | 2.16 | 1.53 | 1.07 | 1.46 | 1.27 | -1.61 | -2.06 | 
| Tax % | 33.95% | 34.14% | 34.18% | 32.68% | 36.10% | 29.12% | 39.81% | 37.25% | 42.06% | 39.73% | 11.02% | -9.32% | |
| 1.79 | 1.92 | 1.56 | 1.72 | 1.54 | 2.02 | 1.30 | 0.96 | 0.63 | 0.89 | 1.13 | -1.46 | -1.94 | |
| EPS in Rs | 4.91 | 5.26 | 4.28 | 4.71 | 4.22 | 5.54 | 3.56 | 2.63 | 1.73 | 2.44 | 3.10 | -4.00 | -5.31 | 
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% | 
| 5 Years: | -1% | 
| 3 Years: | 6% | 
| TTM: | 3% | 
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % | 
| 5 Years: | % | 
| 3 Years: | % | 
| TTM: | -287% | 
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% | 
| 5 Years: | 25% | 
| 3 Years: | 28% | 
| 1 Year: | -25% | 
| Return on Equity | |
|---|---|
| 10 Years: | 4% | 
| 5 Years: | 1% | 
| 3 Years: | 1% | 
| Last Year: | -5% | 
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 
| Reserves | 13.83 | 15.79 | 17.35 | 19.07 | 20.62 | 22.63 | 23.18 | 24.15 | 24.77 | 25.66 | 26.79 | 25.33 | 
| 11.32 | 12.28 | 13.11 | 15.24 | 14.37 | 13.10 | 12.72 | 13.47 | 9.30 | 9.92 | 23.24 | 30.01 | |
| 19.53 | 21.80 | 16.68 | 16.07 | 14.89 | 15.61 | 27.96 | 27.00 | 21.85 | 25.40 | 23.70 | 23.83 | |
| Total Liabilities | 50.10 | 55.29 | 52.56 | 55.80 | 55.30 | 56.76 | 69.28 | 70.04 | 61.34 | 66.40 | 79.15 | 84.59 | 
| 4.53 | 4.13 | 3.64 | 3.71 | 3.80 | 4.08 | 10.44 | 8.97 | 7.60 | 6.46 | 12.77 | 19.99 | |
| CWIP | 0.19 | 0.19 | 0.19 | 0.19 | 0.22 | 0.22 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 
| 45.38 | 50.97 | 48.73 | 51.90 | 51.28 | 52.46 | 58.62 | 61.07 | 53.74 | 59.94 | 66.38 | 64.60 | |
| Total Assets | 50.10 | 55.29 | 52.56 | 55.80 | 55.30 | 56.76 | 69.28 | 70.04 | 61.34 | 66.40 | 79.15 | 84.59 | 
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.25 | 0.21 | -1.51 | 0.00 | 1.76 | 1.55 | 2.08 | 1.97 | 4.75 | 1.30 | 6.21 | 17.07 | |
| -0.42 | -0.36 | -0.19 | -2.38 | -0.64 | -1.02 | -1.31 | -0.89 | -0.17 | -0.18 | -7.92 | -11.61 | |
| -1.34 | 0.96 | 0.82 | 2.14 | -0.88 | -1.27 | -0.37 | -1.27 | -4.87 | -1.05 | 2.06 | -5.93 | |
| Net Cash Flow | -2.01 | 0.80 | -0.88 | -0.25 | 0.24 | -0.75 | 0.40 | -0.18 | -0.28 | 0.07 | 0.35 | -0.47 | 
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 135.08 | 138.21 | 132.75 | 130.76 | 125.29 | 134.80 | 153.26 | 221.39 | 160.44 | 142.71 | 134.05 | 125.56 | 
| Inventory Days | 297.67 | 350.07 | 365.93 | 468.59 | 465.89 | 434.68 | 483.86 | 1,276.44 | 599.23 | 677.26 | 909.72 | 921.61 | 
| Days Payable | 162.36 | 167.34 | 124.26 | 146.28 | 135.64 | 120.26 | 187.98 | 372.75 | 159.00 | 222.42 | 207.75 | 151.98 | 
| Cash Conversion Cycle | 270.39 | 320.94 | 374.42 | 453.06 | 455.54 | 449.22 | 449.14 | 1,125.08 | 600.67 | 597.56 | 836.02 | 895.19 | 
| Working Capital Days | 122.62 | 127.27 | 148.80 | 156.25 | 164.05 | 167.69 | 172.36 | 282.37 | 236.68 | 207.73 | 226.67 | 210.99 | 
| ROCE % | 13.25% | 14.08% | 11.59% | 11.40% | 9.78% | 11.62% | 10.84% | 8.65% | 7.27% | 8.03% | 8.07% | 3.94% | 
Documents
Announcements
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 10 Oct
- 
        
          Intimation Under Regulation 30 SEBI (LODR) Regulations, 2015 Read With Part A Of Schedule III -Reconstitution Of Committee Of The Board.
          
            10 Oct - Audit Committee reconstituted: Neel Vora inducted as member effective October 10, 2025 (Surgical Suture Ltd, Scrip 531380).
- 
        
          Closure of Trading Window
          
            21 Sep - Trading window closed Oct 1, 2025 until 48 hours after Q2/H1 September 30, 2025 results dissemination.
- 
        
          Price Of The Scrip Of Our Company Has Seen An Abnormal Price Rise, Which Was Not Supported By Any Corporate Announcements Or Material Changes In The Business Activities Of Our Company And Manipulative Trade Observed In Our Scrip And Request Urgent Attention For Possible MISUSE / UNETHICAL / UNUSUAL TRADES In Our Company Scrip.
          
            8 Sep - CENTENIAL SURGICAL SUTURE (scrip 531380) alleges manipulation; Sept 8, 2025 price Rs107.80; seeks SEBI probe.
- 
        
          Clarification On Price Movement
          
            4 Sep - Centennial Surgical Suture (Scrip 531380) alleges price manipulation Jan–Aug 2025; requests SEBI/BSE probe and transaction data.
Annual reports
- 
    
      Financial Year 2025
      from bse
- 
    
      Financial Year 2024
      from bse
- 
    
      Financial Year 2023
      from bse
- 
    
      Financial Year 2022
      from bse
- 
    
      Financial Year 2021
      from bse
- 
    
      Financial Year 2020
      from bse
- 
    
      Financial Year 2019
      from bse
- 
    
      Financial Year 2018
      from bse
- 
    
      Financial Year 2017
      from bse
- 
    
      Financial Year 2016
      from bse
- 
    
      Financial Year 2015
      from bse
- 
    
      Financial Year 2014
      from bse
- 
    
      Financial Year 2013
      from bse
- 
    
      Financial Year 2012
      from bse
- 
    
      Financial Year 2011
      from bse
Product Portfolio:
Company manufactures highly specialized absorbable and non-absorbable sutures (cardio vascular sutures and atraumatic needled sutures) that are primarily used in CABG surgeries, and other medical devices. It sells products under:
a) Absorbable Sutures:[1]
Consists of Natural Sutures with brand names like Centenial -Catgut Plain and Centenial-Catgut Chromic in addition to Synthetic Sutures, with brand names like Centicryl, Monosynth and Centisorb
b) Non Absorbable Sutures:[2]
Brand names like Centilene, Centlon Centisilk, Centlinen, Centibond, Centsteel, Centidene
c) Medical Devices:[3]
T-suit, Centilene Mesh, Skin Stapler, Centiclip, Aortic Punch and KNIFE which is a Cardiovascular Vessel Knife